Original Publication Date: 1 November, 2016
Publication / Source: Future Oncology
Authors: Emma Scott, Diana Learoyd & Roderick J Clifton-Bligh
The treatment of papillary thyroid cancer is now based on individual patient risk and response to therapies. Molecular techniques are increasingly being used to risk stratify and to guide therapeutic decisions. There have been advances in the treatment of local disease through surgery or radioiodine. Directed techniques can target metastatic disease including bisphosphonates, radiofrequency ablation or radiotherapy.